Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Decision to treat with DMF must precede enrollment.
Naïve to DMF or fumaric acid esters.
Resides in the US and has a confirmed diagnosis of a relapsing form of MS.
Satisfies the approved therapeutic indication(s) for DMF.
You may not be if
Inability to comply with study requirements or, at the discretion of the Investigator, is deemed unsuitable for study participation.
History of significant GI disease, chronic use of GI symptomatic therapy, active malignancies.
Is participating in any other interventional clinical trial.
Clareo Health | Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States
